（记者 曾健辉） 每经AI快讯，天阳科技9月18日晚间发布公告称，本激励计划拟授予的激励对象总人数共计37人，采取 的激励工具为限制性股票，股票来源为公司从二级市场回购的公司A股普通股股票或/和向激励对象定向 发行的公司A股普通股股票；拟向激励对象授予限制性股票数量不超过约434.65万股，约占本激励计划 草案公告时公司股本总额约4.88亿股的0.89%；限制性股票的授予价格为每股12.08元，即满足归属条件 后，激励对象可以每股12.08元的价格购买公司向激励对象授予的公司A股普通股股票，有效期为自限制 性股票授予之日起至激励对象获授的限制性股票全部归属或作废失效之日止，最长不超过36个月。 每经头条（nbdtoutiao）——"25基点太少，50基点太多"：美联储降息"走钢丝"，"特朗普代言人"投下唯 一反对票 ...

Core Viewpoint - Frontier Biotech (688221) has announced a restricted stock incentive plan for 2025, aiming to attract and retain talent while enhancing the company's core competitiveness and achieving strategic goals [1] Group 1: Incentive Plan Details - The plan includes granting a total of 5 million restricted stocks, with 4.25 million for initial grants and 750,000 reserved, at a price of 8.56 yuan per share [1] - The initial grant will be distributed among 27 employees, representing 8.94% of the total workforce of 302 as of December 31, 2024 [2] - 16 out of the 27 recipients are assessed based on R&D metrics, receiving 3.07 million shares, which accounts for 61.40% of the total shares granted [2] Group 2: Performance Targets - For the first vesting period in 2025, the company must achieve at least one IND application and eight new drug patent applications to meet the 100% vesting requirement [2] - For the second vesting period in 2026, the cumulative targets include five IND applications and 16 new drug patent applications, along with one BD transaction for small nucleic acid drugs [3] - Revenue growth targets are set at a minimum of 10% for 2025 and a cumulative growth of 30% for 2025-2026, based on 2024 revenue [3] Group 3: Focus on Small Nucleic Acid Drugs - The incentive plan emphasizes achieving BD transactions for small nucleic acid drugs, highlighting the company's focus in this area [4] - Frontier Biotech has developed a comprehensive and high-standard development system for small nucleic acid drugs, leveraging internal and external collaborations [4] - The company is advancing multiple drug candidates in various therapeutic areas, including IgA nephropathy and metabolic diseases, all currently in preclinical stages [4] Group 4: Technological Innovations - The company has developed a proprietary siRNA delivery vehicle, ACORDE, which is currently under international patent application [5] - The strategic focus is on innovative drug development and commercialization, marking a critical phase for high-quality business growth [5] - The performance metrics of the incentive plan align with the company's strategic needs and are designed to enhance competitiveness and employee motivation [5]

瑞财经 严明会9月17日，安徽富印新材料股份有限公司(以下简称：富印新材）披露北交所IPO问询回 复，保荐机构民生证券，保荐代表人李守民、田尚清，会计师事务所为中汇会计师事务所。 富印新材成立于2016年，注册资本6808.7万元，公司主要经营精密功能材料的研发、生产、销售和服 务。公司精密功能材料产品广泛应用于智能终端、汽车、家电等领域。 富印新材回复称，涂志兵取得股权激励的背景为：富印有限与深圳市前海钜诚投资咨询有限公司于 2018 年12月签订的《顾问服务协议》，由其作为公司的投融资及IPO辅导顾问，向公司提供投融资及 IPO辅 导顾问服务。 | 海源海汇 | 涂志兵 30.00 | 2021年11月,各方根据 由各方依据附属协议 | 246.6 | | --- | --- | --- | --- | | | | 投资协议及附属协议约 的约定并协商一致按 | | | | 富印参号 136.6667 | 定执行回购。同时,为照原价加年化 12%的 | 1.132.01 | | | | 获取涂志兵及其实际控 收益率确定。 | | 公司本次拟募资4.04亿元，用于精密功能材料生产建设项目(一期)等三大项目以及 ...

Core Viewpoint - Xinjiang Bayi Steel Co., Ltd. announced the repurchase and cancellation of certain restricted stock options due to unmet performance targets and changes in the eligibility of some incentive recipients [1] Group 1: Stock Repurchase Details - The company will repurchase and cancel a total of 5,793,600 shares involving 206 individuals [1] - The repurchase price will be either 3.13 CNY or 3.28 CNY per share, plus interest based on the bank's current term deposit rates [1] - The cancellation is expected to be completed by September 23, resulting in a reduction of the total share capital from 1,538,691,470 shares to 1,532,897,870 shares [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603121 证券简称：华培动力 公告编号：2025-036 上海华培数能科技（集团）股份有限公司 第三届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海华培数能科技（集团）股份有限公司（以下简称"公司"）第三届董事会第十八次会议于2025年9月 17日（星期三）在上海市青浦区崧秀路218号以现场结合通讯的方式召开。会议通知已于2025年9月12日 通过邮件的方式送达各位董事。本次会议由公司董事长吴怀磊先生主持，应出席董事9人，实际出席董 事9人。公司高级管理人员列席了会议。本次会议的召开符合《公司法》和《公司章程》及其他有关法 律法规的规定。 二、董事会会议审议情况 （一）审议通过了《关于以集中竞价交易方式回购公司股份的议案》 基于对公司未来发展的信心和对公司价值的认可，为建立完善的公司长效激励机制，充分调动公司员工 的积极性，有效地将股东利益、公司利益和员工个人利益紧密结合在一起，促进公司健康可持续发展， 在 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603121 证券简称：华培动力 公告编号：2025-037 上海华培数能科技（集团） 股份有限公司关于以集中竞价 交易方式回购股份的预案 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份金额：不低于人民币1,000万元（含），不高于人民币2,000万元（含） ● 回购股份资金来源：自有资金或自筹资金 ● 回购股份用途：本次回购的股份拟全部用于上海华培数能科技（集团）股份有限公司（以下简称"公 司"）股权激励及/或员工持股计划。公司如未能在股份回购实施完成之后36个月内使用完毕已回购的股 份，尚未使用的已回购股份将予以注销； ● 回购股份价格：不超过人民币27.42元/股（含），该价格不高于公司董事会通过回购股份决议前30个 交易日公司股票交易均价的150%； ● 回购股份方式：拟通过上海证券交易系统以集中竞价交易的方式进行股份回购； ● 回购股份期限：自公司董事会审议通过本次回购股份方案之日起12个月内； ● 相关股东是否存在减持计划 ...

Core Viewpoint - The company is focusing on its core business of AGV intelligent logistics robots and plans to expand its market presence, particularly in emerging markets like Southeast Asia and India, while maintaining strong cost control and optimizing production processes [1][2]. Group 1: Business Operations - The company specializes in AGV intelligent logistics robots, offering customized R&D and production capabilities to meet diverse industry needs [1]. - The order situation remains stable, with business levels comparable to the previous year, and delivery times vary based on product customization, ranging from 2 months for small equipment to over 6 months for large machinery [2]. - The company employs a project-based and digital management approach to monitor and control product quality and costs throughout the sales and production processes [2]. Group 2: Financial Performance - The net profit growth in the semi-annual report is attributed to optimized sales structure, increased R&D investment, lean management practices, enhanced cost control, and effective handling of exchange rate fluctuations [2]. - The company has been recognized in the all-steel radial tire forming machine sector as a national manufacturing champion, collaborating with various well-known domestic and international tire manufacturers [2]. Group 3: Future Growth and Strategy - Future revenue growth is expected to come from deepening engagement in the tire equipment industry, enhancing R&D innovation, and introducing new technologies to meet customer demands [2]. - The company plans to leverage its brand influence and maintain its competitive edge by providing high-quality products and services, with potential for equipment offerings in other sectors through production chain modifications [2]. Group 4: Market and Investor Relations - The company is committed to enhancing performance through core business focus and effective investor relations management, including reasonable profit distribution policies [3]. - Stock buyback initiatives were undertaken in 2021, with plans for employee stock ownership programs in 2023 and 2025 [3].

Core Viewpoint - Equity incentives are becoming a norm in the domestic capital market, serving as an important mechanism for listed companies to improve internal governance [1] Group 1: Overview of Equity Incentives in Sichuan - As of September 17, there are 179 A-share listed companies in Sichuan, with 9 companies implementing equity incentives this year, involving over 1,250 individuals [1] - All 9 companies that have implemented equity incentives are private enterprises, indicating that private companies are the main force behind the promotion of equity incentives in Sichuan [1] - The companies implementing equity incentives span multiple industries, with the defense and military industry being the most concentrated, having 4 companies, followed by the pharmaceutical and biotechnology industry with 2 companies, and the computer, construction decoration, and basic chemical industries with 1 company each [1] Group 2: Specific Companies and Their Incentive Plans - Chengdu XianDao set the grant date for its restricted stock incentive plan as September 15, 2025, granting 1,052,200 shares at a price of 13.99 yuan per share to 102 eligible recipients [1] - Kangtong Medical confirmed the grant date for its restricted stock incentive plan as July 22, 2025, granting 1,230,000 shares at a price of 10.01 yuan per share to 80 eligible recipients [2] - Huatu Shanding determined the initial and reserved grant dates for restricted stocks as July 15, granting a total of 3,049,480 shares at a price of 32.76 yuan per share to 338 individuals [3] - Jiachitech granted 1,187,000 shares of the second category of restricted stocks to 62 eligible recipients on June 3, at a price of 27.86 yuan per share [4] - Junyi Digital set June 20 as the grant date, granting a total of 7,000,000 stock options to 45 eligible recipients at an exercise price of 19.07 yuan per share [5] - Aileda granted 2,814,000 shares of the second category of restricted stocks to 220 eligible recipients on May 16, at a price of 9.25 yuan per share [8] - Zongheng Co. granted 1,735,000 shares of the second category of restricted stocks to 95 eligible recipients on April 17, at a price of 21.68 yuan per share [9] - Qiaoyuan Co. granted 739,700 shares of restricted stocks to 229 eligible recipients on February 27, with a price of 17.64 yuan per share [10]

Core Viewpoint - Semir Apparel reported a significant decline in net profit for H1 2025, with a net profit attributable to shareholders of 330 million yuan, down 41.2% year-on-year, and a net profit of 300 million yuan after deducting non-recurring gains and losses, down 45.2% year-on-year, indicating challenges in the retail environment [1] Financial Performance - The company achieved a dividend payout ratio of 124% in H1 2025, reflecting a commitment to returning value to shareholders despite profit pressures [1] - Revenue showed resilience against a fluctuating retail environment, attributed to proactive store openings and brand marketing efforts, although increased expenditure has temporarily pressured profit margins [1] Channel Development - Direct sales channels demonstrated high-quality growth, showcasing the effectiveness of the company's channel transformation [1] - Franchise income experienced a slight decline, primarily due to a weak retail environment, with net changes in direct and franchise stores being +19 and -66, respectively, resulting in 999 direct stores and 7,194 franchise stores [1] Brand Strength and Future Outlook - The company has a strong brand presence in the apparel industry, particularly with its main brands, Balabala and Semir, which are expected to benefit from store expansion and organizational changes [1] - The upcoming stock incentive plan to be announced in September 2024 reflects the company's confidence in its development prospects [1] - The company maintains a "Buy" rating, anticipating performance recovery as the retail environment improves [1]

Core Viewpoint - The Chinese engineering machinery industry has entered a new growth cycle, with listed companies seizing opportunities to expand in various dimensions such as emerging applications, overseas markets, niche segments, and talent incentives [1] Group 1: Emerging Applications - Deepening new application scenarios is crucial for companies to explore new performance growth "mines" beyond traditional infrastructure [2] - The industry should focus on emerging areas like renewable energy, agriculture, and municipal upgrades, leveraging technological advantages to create new growth engines [2] Group 2: Overseas Localization - Companies need to transition from merely exporting products to establishing a localized presence in overseas markets [2] - This involves localizing the entire chain of "R&D, production, and service" to integrate "Chinese manufacturing" into local markets, thus transforming market variables into constants [2] Group 3: Niche Markets - Companies should delve into niche markets to uncover overlooked demands and build exclusive competitive advantages through customized products [3] - Identifying and capitalizing on the potential of each niche can lead to unique business opportunities [3] Group 4: Talent Incentives - Binding high-end talent through equity incentives is essential for activating innovation within the technology-intensive engineering machinery sector [4] - This approach creates a foundation for synchronized growth between individual and collective interests, forming a key support for building a community of shared benefits [4] Group 5: Integrated Strategy - The four dimensions of emerging applications, overseas localization, niche market focus, and talent binding are interrelated strategies that collectively drive industry development [4] - Companies must leverage these "four keys" to activate new engines of growth and navigate the global market effectively [4]